Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 Next >
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
Tags Health & Science Companies Social issues
From CNBC.com News
Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.
Tags Politics Policy Breaking News: Politics
From CNBC.com News
More than 3 million Medicare patients could be eligible for coverage of Wegovy to reduce heart disease risks, study says
Tags Pharmaceuticals Breaking news Biotechnology
From CNBC.com News
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
Tags Jack in the Box Inc CAVA Group Inc Health care industry
From CNBC.com News
Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says
Tags Eli Lilly and Co Health & Science Companies
From CNBC.com News
Eli Lilly’s Zepbound shows promise as a sleep apnea treatment in late-stage trials
Tags Business News Biotech and Pharmaceuticals Health care industry
From CNBC.com News
EU probe of weight loss and diabetes drugs like Wegovy, Ozempic finds no link to suicidal thoughts
Tags Breaking news Pharmaceuticals Business
From CNBC.com News
Diabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trial
Tags Pharmaceuticals Novo Nordisk A/S Sanofi SA
From CNBC.com News
Danone CEO downplays threat of weight loss drugs on food producers: 'We see ourselves as extremely complementary'
Tags Health & Science Food and drink Danone SA
From CNBC.com News
Healthy Returns: Weight loss, diabetes drug ad spending tops $1 billion
Tags Eli Lilly and Co AstraZeneca PLC Healthy Returns
From CNBC.com News
Altimmune says weight loss drug minimized muscle loss in trial results that may set it apart
Tags Pharmaceuticals Business US: News
From CNBC.com News
Novo Nordisk's $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests
Tags Health care industry Business News Biotech and Pharmaceuticals
From CNBC.com News
Viking Therapeutics stock jumps 15% on promising weight loss pill data
Tags Breaking news Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Amgen wants in on the booming weight loss drug market — and it's taking a different approach
Tags Eli Lilly and Co Companies Health & Science
From CNBC.com News
Two fresh ways to play the weight loss and megacap tech hype
Tags Novo Nordisk A/S Markets Breaking News: Investing
From CNBC.com News
Here's how much people are willing to spend on weight loss drugs, according to a new survey
Tags Social issues Eli Lilly and Co Health & Science
From CNBC.com News
Cramer's Lighting Round: Arm is a buy
Tags Unity Software Inc General Electric Co Market Outlook
From CNBC.com News
Medicare can now cover certain weight loss drugs in a big step for patients
Tags Business News Biotech and Pharmaceuticals Health care industry
From CNBC.com News
Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
Tags Novo Nordisk A/S Alphabet Inc Akero Therapeutics Inc
From CNBC.com News
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
Tags Breaking news Pharmaceuticals US: News
From CNBC.com News
FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
Tags Companies Health & Science Breaking News: Business
From CNBC.com News
Weight Watchers CEO just sent an internal memo to employees as stock crashes, amid debt concerns, Oprah exit
Tags Weight loss diets Health & Science Pharmaceuticals
From CNBC.com News
Experts hesitate on weight loss ETFs amid the obesity drug boom
Tags Health Health care industry U/S/ Markets
From CNBC.com News
Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients
Tags Breaking news Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Jim Cramer reviews Citi's European 'Super Seven'
Tags Eaton Corporation PLC Business Investing
From CNBC.com News
Novo Nordisk's Wegovy wins FDA approval for heart health benefits, in move that could expand insurance coverage
Tags Breaking News: Business Business News Social issues
From CNBC.com News
Novo Nordisk CEO says experimental weight loss pill could become a best in class drug
Tags Business US: News Health care industry
From CNBC.com News
Novo Nordisk market cap surpasses Tesla on new obesity pill trial data
Tags Pharmaceuticals Markets Tesla Inc
From CNBC.com News
Novo Nordisk shares jump 5% on promising weight loss trial results; Eli Lilly dips
Tags Investment strategy Eli Lilly and Co Breaking News: Investing
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic slashed the risk of kidney disease progression in trial
Tags Eli Lilly and Co Science Health & Science
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.